The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study

Brigham and Women's Hospital120 enrolled

Overview

Individuals with rheumatoid arthritis (RA) have up to 2x the risk of having a heart attack compared to someone without RA. The goal of this study is to identify biomarkers that can help us do a better job of identifying individuals at risk before they develop symptoms of heart disease and start preventative treatment earlier.

The objective of this study is to test the utility of high sensitivity cardiac troponin (hs-cTn) and coronary artery calcium (CAC) in risk stratifying patients with rheumatoid arthritis (RA) who may benefit from lipid lowering therapy. The population of interest are individuals who would not otherwise be recommended for therapy based on general population risk calculators for heart disease risk.

Study Type

OBSERVATIONAL

Enrollment

120

Conditions

Rheumatoid Arthritis (RA Atherosclerotic Cardiovascular Disease (ASCVD)

Interventions

high sensitivity cardiac troponinDIAGNOSTIC_TEST

Blood measurement of high sensitivity cardiac troponin

Eligibility

Sex: ALLMin age: 35 YearsMax age: 79 Years

Medical Language ↔ Plain English

Inclusion Criteria: * RA diagnosed by a rheumatologist * Age 40- 79 * ≥1 ASCVD risk factor including prediabetes, hypertension, BMI \>30, current or history of cigarette smoking Exclusion Criteria: * Patients on a statin or with a contraindication to statin, on a cholesterol absorption inhibitor, or on a PCSK9 inhibitor * Patients with diabetes mellitus * Pregnancy

Locations (1)

Brigham and Womens Hospital

Boston, Massachusetts, United States

RECRUITING

Outcomes

Primary Outcomes

coronary artery calcium score

Quantified coronary artery calcium score

Time frame: Cross-sectional, at baseline

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.